0000950103-20-003118.txt : 20200221 0000950103-20-003118.hdr.sgml : 20200221 20200221175435 ACCESSION NUMBER: 0000950103-20-003118 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200219 FILED AS OF DATE: 20200221 DATE AS OF CHANGE: 20200221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sumitomo Chemical Co., Ltd. CENTRAL INDEX KEY: 0001798550 STATE OF INCORPORATION: M0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38667 FILM NUMBER: 20641407 BUSINESS ADDRESS: STREET 1: 27-1, SHINKAWA 2-CHOME STREET 2: CHUO-KU CITY: TOKYO STATE: M0 ZIP: 104-8260 BUSINESS PHONE: 813-5543-5142 MAIL ADDRESS: STREET 1: 27-1, SHINKAWA 2-CHOME STREET 2: CHUO-KU CITY: TOKYO STATE: M0 ZIP: 104-8260 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dainippon Sumitomo Pharma Co Ltd CENTRAL INDEX KEY: 0001446601 STATE OF INCORPORATION: M0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38667 FILM NUMBER: 20641408 BUSINESS ADDRESS: STREET 1: 60 WALL STREET CITY: NEW YORK STATE: NY ZIP: 10005 BUSINESS PHONE: 212-319-7600 MAIL ADDRESS: STREET 1: 60 WALL STREET CITY: NEW YORK STATE: NY ZIP: 10005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sumitovant Biopharma Ltd. CENTRAL INDEX KEY: 0001798244 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38667 FILM NUMBER: 20641409 BUSINESS ADDRESS: STREET 1: SUITE 1, 3RD FLOOR STREET 2: 11-12 ST. JAMES SQUARE CITY: LONDON STATE: X0 ZIP: SW1Y 4LB BUSINESS PHONE: (646) 802-3660 MAIL ADDRESS: STREET 1: C/O ROIVANT SCIENCES, INC. STREET 2: 320 WEST 37TH STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Urovant Sciences Ltd. CENTRAL INDEX KEY: 0001740547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 5281 CALIFORNIA AVENUE STREET 2: SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 BUSINESS PHONE: 949-226-6029 MAIL ADDRESS: STREET 1: 5281 CALIFORNIA AVENUE STREET 2: SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 4 1 dp121731_4-sumitomo.xml X0306 4 2020-02-19 0 0001740547 Urovant Sciences Ltd. UROV 0001798550 Sumitomo Chemical Co., Ltd. 27-1, SHINKAWA 2-CHOME CHUO-KU TOKYO M0 104-8260 JAPAN 0 0 0 1 See Footnote (1) 0001446601 Dainippon Sumitomo Pharma Co Ltd 6-8 DOSHOMACHI 2-CHOME CHUO-KU OSAKA M0 541-0045 JAPAN 0 0 0 1 See Footnote (1) 0001798244 Sumitovant Biopharma Ltd. 11-12 ST. JAMES'S SQUARE SUITE 1 3RD FLOOR LONDON X0 SW1Y 4LB UNITED KINGDOM 0 0 1 0 Common Stock 2020-02-19 4 P 0 12873 13.08 A 22872886 I See Footnote Common Stock 2020-02-19 4 P 0 15165 13.08 A 22888051 I See Footnote Common Stock 2020-02-19 4 P 0 75212 13.08 A 22963263 I See Footnote Sumitovant Biopharma Ltd. ("Sumitovant") directly owns 22,963,263 shares of Common Stock. Sumitovant is a wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon"), which is a 51.76% owned subsidiary of Sumitomo Chemical Co., Ltd. ("Sumitomo Chemical"). Sumitomo Dainippon and Sumitomo Chemical may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) the reported securities that Sumitovant owns. Each of Sumitomo Dainippon and Sumitomo Chemical disclaims beneficial ownership of such reported securities except to the extent of their pecuniary interest therein. Sumitomo Chemical Co., Ltd. By: Yoshiaki Oda, Managing Executive /s/ Yoshiaki Oda 2020-02-21 Sumitomo Dainippon Pharma Co., Ltd. By: Yumi Sato, Senior /s/ Yumi Sato 2020-02-21 Sumitovant Biopharma Ltd. By: Marianne L. Romeo, Authorized /s/ Marianne L. Romeo 2020-02-21